Experts concerned over mixed results from Takeda's dengue va...

Takeda’s dengue vaccine has met its target of protection against the disease in children – but there are already concerns about mixed results among different strains of the potentially dead

UK startup Ervaxx targets ‘dark matter’ of human genome

Lilly and Boehringer rejig diabetes alliance as Jardiance so...

Eli Lilly and Boehringer Ingelheim have changed the terms of their diabetes alliance to focus their energies on developing their big-selling Jardiance pill.

Sanofi builds case for Toujeo in younger type 1 diabetics

Chinese pharma claims first Alzheimer's drug approval since ...

China’s drugs regulator has conditionally approved Shanghai Green Valley Pharmaceuticals’ Oligomannate to improve cognitive function in mild to moderate Alzheimer’s disease, the first novel

Novartis’ Cosentyx didn’t EXCEED Humira in psoriatic arthrit...